CLU-RX-OLE low dose clinical trials

Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from Olea europaea pollen allergy

This study is testing a new treatment for olive pollen allergy. It's looking at how well different doses of an injection, called CLU-RX-OLE, can reduce allergy symptoms like sneezing and runny nose, and if it's safe to use.